Skip to content

Clinical trials

Completed Adenocarcinoma trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Status: Completed Country / region: South Korea Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20072
20082
20092
20102
20142
20151
20163
20172
20191
20202
20212
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim2
Daiichi Sankyo Co., Ltd.2
Eli Lilly and Company2
Novartis Pharmaceuticals2
Ariad Pharmaceuticals1
Asan Medical Center1
Australasian Gastro-Intestinal Trials Group1
Celgene1
Chonnam National University Hospital1
Genzyme, a Sanofi Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma24
Carcinoma, Non-Small-Cell Lung7
Carcinoma6
Neoplasms6
Lung Neoplasms5
Stomach Neoplasms5
Digestive System Diseases4
Digestive System Neoplasms4
Neoplasm Metastasis4
Neoplasms by Site4

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.